Adjunct to diet & exercise in adults w/ type 2 DM as monotherapy or in combination w/ metformin as initial therapy in treatment-naive patients w/ inadequate glycaemic control by diet & exercise alone, or in patients w/ inadequate glycaemic control w/ max tolerated dose of metformin alone or as triple combination w/ metformin & sulfonylurea in patients w/ inadequate glycaemic control w/ max tolerated dose of metformin & sulfonylurea dual therapy.
Not recommended in patients w/ NYHA Class II-IV cardiac status; history of pancreatitis; risk of hypoglycaemia; severe & disabling arthralgia; concomitant use w/ sulfonylurea. Contains sunset yellow FCF. Hepatic impairment. Pregnancy & lactation. Childn <18 yr. Elderly.